Fosun International LTD Jounce Therapeutics, Inc. Transaction History

Fosun International LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$7.27 - $21.88 $1.16 Million - $3.5 Million	-160,000 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$13.4 - $28.4 $1.69 Million - $3.58 Million	-125,960 Reduced 44.05%	160,000 $3.58 Million
Q3 2017 Nov 14, 2017	BUY	$11.17 - $16.99 $3.19 Million - $4.86 Million	285,960	285,960 $4.46 Million

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.